LifeStance Health (LFST) Receivables - Net (2020 - 2026)

LifeStance Health has disclosed Receivables - Net across 7 years of filings, most recently posting $122.9 million for Q1 2026.

• In Q1 2026, Receivables - Net fell 12.43% year-over-year to $122.9 million; the TTM figure through Mar 2026 stood at $122.9 million (down 12.43% YoY), while the FY2025 annual figure was $95.7 million, down 27.38% from the prior year.
• Receivables - Net grew to $122.9 million in Q1 2026, from $95.7 million in the prior quarter.
• Over the last five years, Receivables - Net for LFST reached as high as $175.9 million in Q1 2024 and fell as low as $95.0 million in Q1 2022.
• The 5-year median for Receivables - Net is $122.9 million (2026), against an average of $127.5 million.
• Annual changes were most pronounced in 2022 — Receivables - Net surged 66.04% — and 2025, when it slipped 27.38%.
• A 5-year view of Receivables - Net shows it stood at $100.9 million in 2022, then gained by 24.33% to $125.4 million in 2023, then increased by 5.1% to $131.8 million in 2024, then fell by 27.38% to $95.7 million in 2025, then rose by 28.43% to $122.9 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $122.9 million, $95.7 million, and $121.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.